Skip to main content
Caplight Logo









Hunter Biotechnology

Hunter Biotechnology

Private
HangzhouHealthcare & Life Scienceshttps://zhunter.com/

Company Overview

Hunter Biotechnology operates in Healthcare & Life Sciences and is based in Hangzhou.

Hunter Biotechnology is a biotechnology company that provides zebrafish-based efficacy and safety evaluation services for the pharmaceutical, nutritional health, and cosmetic industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Hunter Biotechnology Comparables

Compare Hunter Biotechnology with similar companies based on industry and business-model similarity.

Hunter Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ZeClinics
89%
Pentagrit
89%
ZebraPeutics (Zhongshan) Ltd.
88%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Hunter Biotechnology Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Hunter Biotechnology. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 30, 2026

    Monthly visitors increased 1468% MoM, from 50 to 784.

Book a demo to see all signals

For institutional investors. Book with your work email.

Hunter Biotechnology Filings

Explore SEC and related filing metadata, where available.

Hunter Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Hunter Biotechnology's valuation, stock price, and market status.

Is Hunter Biotechnology a public or private company?

Hunter Biotechnology is a private company.

What is the current stock price of Hunter Biotechnology?

Hunter Biotechnology is a private company, so its shares have no public market price. Caplight tracks Hunter Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Hunter Biotechnology worth (valuation)?

Valuation information for Hunter Biotechnology is not publicly available.

Can I buy Hunter Biotechnology stock?

Hunter Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Hunter Biotechnology's last funding round?

Funding round information for Hunter Biotechnology is not publicly available.

Who are the main investors in Hunter Biotechnology?

Investor information for Hunter Biotechnology is not publicly disclosed.

Will Hunter Biotechnology IPO soon?

No public IPO plans have been announced for Hunter Biotechnology.

How can I track Hunter Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades in Hunter Biotechnology's shares on secondary markets.

Firmographic Details

HeadquartersHangzhou
Employee Range9
Year FoundedN/A
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?